by GlobeNewsWire | Sep 9, 2015 | Client News, Feature Box, Featured, Globe Newswire, Health Stock, Medical, Medical Stocks, Pharmaceutical
Strong Efficacy Signal Established in Genetically Identified Subset of ADHD PatientsDevelopment will Include Neuropsychiatric Symptoms of 22q11.2 Deletion SyndromePHILADELPHIA, Sept. 9, 2015 (GLOBE NEWSWIRE) — Medgenics, Inc. (NYSE MKT:MDGN) today announced the...
by GlobeNewsWire | Sep 4, 2015 | Client News, Globe Newswire, Mining
Fonon Corporation (Formerly Mabwe Minerals Inc.) Receives Clearance From FINRA Including Authorization for 10:1 Stock Split and Issued New Ticker Symbol: FNONLAKE MARY, Fla., Sept. 04, 2015 (GLOBE NEWSWIRE) — Fonon Corporation (formerly Mabwe Minerals)...
by GlobeNewsWire | Sep 4, 2015 | Client News, Globe Newswire, Tech Stocks, Technology, Technology Stocks
FREMONT, Calif., Sept. 4, 2015 (GLOBE NEWSWIRE) — Aehr Test Systems (NASDAQ: AEHR), a worldwide supplier of semiconductor test and burn-in equipment, today announced the appointment of Corporate Controller Kenneth B. Spink as Chief Financial Officer and VP of...
by GlobeNewsWire | Sep 3, 2015 | Client News, Dividend Stock, Globe Newswire
HOUSTON, Sept. 3, 2015 (GLOBE NEWSWIRE) — Quanex Building Products Corporation (NYSE:NX) a leading components supplier for the global window and door industry, today announced that its Board of Directors declared a quarterly cash dividend of $0.04 per share on...
by GlobeNewsWire | Sep 3, 2015 | Client News, Globe Newswire
DALLAS, Sept. 3, 2015 (GLOBE NEWSWIRE) — Fogo de Chão (NASDAQ:FOGO) today announced it will open five new Company-owned restaurant locations in the United States. Fogo opened its first U.S. restaurant in 1997 in Dallas, Texas, and currently operates 26...
by GlobeNewsWire | Sep 3, 2015 | Biotech, Client News, Globe Newswire, Medical, Medical Stocks
ROCKVILLE, Md., Sept. 03, 2015 (GLOBE NEWSWIRE) — MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, as well as...